Literature DB >> 12653556

Polyproline type II conformation in the C-terminal domain of the nuclear pore complex protein gp210.

Yair Pilpel1, Oren Bogin, Vlad Brumfeld, Ziv Reich.   

Abstract

gp210 is a major constituent of the nuclear pore complex (NPC) with possible structural and regulatory roles. It interacts with components of the NPC via its C-terminal domain (CTD), which follows a transmembrane domain and a massive ( approximately 200 kDa) N-terminal region that resides in the lumen of the perinuclear space. Here, we report the solution structure of the human gp210 CTD as determined by various spectroscopic techniques. In water, the CTD adopts an extended, largely unordered conformation, which contains a significant amount of left-handed polyproline type II (PII) helical structure. The conformation of the CTD is altered by high pH, charged detergents, and the hydrogen bond-promoting reagent trifluoroethanol (TFE), which decrease the PII fraction of the fragment. TFE also induces a conformational change in a region containing an SPXX motif whose serine becomes specifically phosphorylated during mitosis. We propose that PII elements in the CTD may play a role in its interaction with the NPC and may serve as recognition sites for regulatory proteins bearing WW or other, unknown PII-binding motifs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12653556     DOI: 10.1021/bi0266176

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  2 in total

1.  Nuclear pore protein gp210 is essential for viability in HeLa cells and Caenorhabditis elegans.

Authors:  Merav Cohen; Naomi Feinstein; Katherine L Wilson; Yosef Gruenbaum
Journal:  Mol Biol Cell       Date:  2003-07-11       Impact factor: 4.138

2.  Despite WT1 binding sites in the promoter region of human and mouse nucleoporin glycoprotein 210, WT1 does not influence expression of GP210.

Authors:  Magnus Olsson; Milton A English; Jacqueline Mason; Jonathan D Licht; Peter Ekblom
Journal:  J Negat Results Biomed       Date:  2004-12-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.